HBV- and HCV- infected workers in the Japanese workplace

Rie Narai1, Tsunehiro Oyama, Masanori Ogawa

  • 1Department of Environmental Health, University of Occupational and Environmental Health, Kitakyushu, Japan.

Insights

Hepatitis B (HBV) and C (HCV) infected workers often face workplace challenges. While hazardous work rates are similar to the general population, many experience hepatitis exacerbations, with concerns about work-related causes.

Area of Science:

  • Occupational Health
  • Hepatology
  • Public Health

Background:

  • Approximately 3 million Japanese individuals have persistent Hepatitis B (HBV) or C (HCV) infections.
  • Limited understanding exists regarding the workplace conditions for these infected workers.

Purpose of the Study:

  • To investigate the workplace conditions and experiences of workers with HBV or HCV infections.
  • To identify factors contributing to hepatitis exacerbation in the workplace.

Main Methods:

  • Conducted three types of questionnaire surveys involving occupational health physicians and workers with hepatitis.
  • Analyzed data from 130,092 workers to determine the prevalence of HBV and HCV infections.
  • Assessed the types of work, exacerbation rates, and perceived causes of exacerbation.

Main Results:

  • Occupational health physicians identified 0.82% of workers with HBV and 0.48% with HCV.
  • Around 30% of infected workers engaged in hazardous work, comparable to the general workforce.
  • Approximately 30% of physicians and 22% of workers reported hepatitis exacerbations, with workers expressing concern about work-related causes.

Conclusions:

  • Workers with hepatitis have significant concerns about the link between their work and disease exacerbation.
  • While hazardous work prevalence is similar, perceived work-related causes and actual exacerbations highlight a need for workplace support and awareness.
  • Further research is needed to elucidate the specific work-related factors contributing to hepatitis exacerbation.

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Standard Precaution01:26

Standard Precaution

Standard precautions are the minimum infection control safeguards used while caring for all patients, irrespective of their disease condition. They help prevent the spread of common infectious microorganisms to healthcare workers, patients, and visitors in all healthcare settings.
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...